Colinz Laboratories

Colinz Laboratories P/FCF

The P/FCF (Price-to-Free-Cash-Flow Ratio) of Colinz Laboratories (531210.BO) as of Oct 16, 2026 is 5.99. In the previous year, P/FCF (Price-to-Free-Cash-Flow Ratio) was -8.87 — a change of -167.51% (higher).

P/FCF

5.99

YoY

-167.51%

Last updated:

P/FCF (Price-to-Free-Cash-Flow Ratio) of Colinz Laboratories is 2026 5.99 . P/FCF (Price-to-Free-Cash-Flow Ratio) of Colinz Laboratories was 2025 -8.87 . It decreases by -167.51% higher compared to the previous year.

The Colinz Laboratories P/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/FCF
Date
P/FCF
Jan 1, 2019
131.22 INR
Jan 1, 2020
28.36 INR
Jan 1, 2021
7.61 INR
Jan 1, 2022
35.44 INR
Jan 1, 2023
37.79 INR
Jan 1, 2024
14.71 INR
Jan 1, 2025
-8.87 INR
Jan 1, 2026
5.99 INR
The Colinz Laboratories P/FCF history
YEARP/FCFYoY
5.99-167.51%
-8.87-160.31%
14.71-61.06%
37.79+6.63%
35.44+365.61%
7.61-73.16%
28.36-78.39%
131.22+190.10%
45.23-88.14%
381.40+1,338.81%
26.51-83.97%
165.39+592.54%
23.88—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Colinz Laboratories Stock analysis

What does Colinz Laboratories do? Colinz Laboratories Ltd, listed on the Bombay Stock Exchange with ticker 531210.BO and ISIN INE923C01011, is a pharmaceutical company headquartered in Mumbai, India. The company operates within the Health Care sector, specifically in the Pharmaceuticals industry. It went public through an IPO on January 13, 2004. Colinz Laboratories is engaged in the manufacturing and marketing of pharmaceutical formulations across various dosage forms, including tablets, capsules, granules, liquid orals, injectables, ointments, and creams. The company's product portfolio targets several medical conditions, such as hypertension, cholesterol, diabetes, piles, pyrexia, and malaria, with specific offerings for gynecological treatments like morning sickness, infertility, intrauterine growth restriction (IUGR), and pregnancy maintenance. Additionally, it provides hematinic, antispasmodic, anti-inflammatory, anti-allergic, and medicated shampoo products. Colinz Laboratories markets its products directly within several Indian states, including Maharashtra, Karnataka, Andhra Pradesh, Gujarat, Rajasthan, Madhya Pradesh, Chhattisgarh, and West Bengal, utilizing its own marketing team. The company's website is www.colinz.com. It is important to note that the company's operations and product details are based on the provided information without additional verification. Colinz Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Colinz Laboratories stock

P/FCF (Price-to-Free-Cash-Flow Ratio) of Colinz Laboratories is 5.99 in 2026.

P/FCF (Price-to-Free-Cash-Flow Ratio) of Colinz Laboratories changed from -8.87 to 5.99, representing a -167.51% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/FCF (Price-to-Free-Cash-Flow Ratio) Colinz Laboratories since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Free-Cash-Flow ratio measures how much investors pay for each unit of free cash flow. A lower ratio may indicate better value.

P/FCF = Market Capitalization / Free Cash Flow

To evaluate P/FCF (Price-to-Free-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/FCF (Price-to-Free-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/FCF (Price-to-Free-Cash-Flow Ratio)'s Colinz Laboratories with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Colinz Laboratories

All Key Metrics — Colinz Laboratories